Picard Medical CEO Patrick Schnegelsberg steps down; Chairman Richard Fang named interim CEO

Picard Medical, Inc.

Patrick NJ Schnegelsberg resigned as CEO and board member effective June 18, 2026; departure not related to any disagreement.
Board appointed Richard Fang, Ph.D., current Chairman, as Interim CEO effective June 18, 2026; he will serve until permanent successor found.
Dr. Fang previously served as CEO from 2021 to 2023; founded Reach Surgical and has over 20 years med-tech experience.
As Interim CEO, Dr. Fang will receive an annual salary of $400,000.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Richard Fang

Interim Chief Executive Officer

PMI · Picard Medical, Inc.

Effective: 2026-06-18
Filed: June 24, 2026, 7:45 AM ET

The Board appointed Richard Fang, Ph.D., 60, as the Company's Interim Chief Executive Officer, effective as of the Separation Date.

Departed

Patrick NJ Schnegelsberg

Chief Executive Officer and Director

PMI · Picard Medical, Inc.

Effective: 2026-06-18
Successor: Richard Fang
Filed: June 24, 2026, 7:45 AM ET

On June 17, 2026, Patrick NJ Schnegelsberg notified Picard Medical, Inc. (the "Company") of his decision to step down as Chief Executive Officer and as a member of the Board of Directors of the Company (the "Board"), effective June 18, 2026

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Richard Fang was appointed as Interim Chief Executive Officer at Picard Medical, Inc..

Action: appointed
Role: Interim Chief Executive Officer

Exact text from the filing

The Board appointed Richard Fang, Ph.D., 60, as the Company's Interim Chief Executive Officer, effective as of the Separation Date.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Patrick NJ Schnegelsberg resigned as Chief Executive Officer and Director at Picard Medical, Inc..

Action: resigned
Role: Chief Executive Officer and Director

Exact text from the filing

On June 17, 2026, Patrick NJ Schnegelsberg notified Picard Medical, Inc. (the "Company") of his decision to step down as Chief Executive Officer and as a member of the Board of Directors of the Company (the "Board"), effective June 18, 2026

View on SEC.gov

Picard Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-26-021504

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.